FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
United States.Congress.House.Committee on Energy and Commerce.Subcommittee on Oversight and Investigations.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,
1989-1991.
Distributed to some depository libraries in microfiche.
Shipping list no.: 89-711-P (pt. 1)
"Second session"--Pt. 4-5.
"May 3, 10, and 11, 1989"--Pt. 1.
"May 3, July 11, and 27, 1989"--Pt. 2.
"September 11 and November 17, 1989"--Pt. 3.
"June 20 and July 18, 1990"--Pt. 4.
"October 15, December 19 and 20, 1990"--Pt. 5.
"Serial no. 101-63"--Pt. 1.
"Serial no. 101-115"--Pt. 2.
"Serial no. 101-117"--Pt. 3.
"Serial no. 101-205"--Pt. 4.
"Serial no. 101-220"--Pt. 5.
Item 1019-A, 1019-B (MF)
Includes bibliographical references.
United States. Food and Drug Administration.
Generic drugs
Pharmaceutical policy